29 reports

The drug candidate acts by targeting pollen allergen Bet v ##.

  • Allergy
  • Digestive System Disorder
  • Healthcare
  • Immunotherapy
  • Therapy

PATIENTS WERE RANDOMIZED IN A ##:## FASHION TO ACTIVE DRUG VERSUS PLACEBO.

  • Allergy
  • Chronic Disease
  • Digestive System Disorder
  • Healthcare
  • Aimmune Therapeutics, Inc.

Patients were randomized in a ##:## fashion to active drug versus placebo.

  • Allergy
  • Chronic Disease
  • Digestive System Disorder
  • Healthcare
  • Aimmune Therapeutics, Inc.

Food and Drug Administration (FDA) has approved RAGWITEK™ (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use (## Amb a ##-U).

  • Allergy
  • Digestive System Disorder
  • Healthcare
  • Therapy
  • Biomay AG

Cat allergy is an allergic reaction to one or more allergens produced by cats.

  • Allergy
  • Chronic Disease
  • Healthcare
  • World
  • Product Initiative

" House dust mite allergy is one of the most common allergies, impacting the quality of life for patients across ages and geographies.

  • Allergy
  • Allergy Immunotherapy
  • Digestive System Disorder
  • Healthcare
  • Therapy

Patients were randomized in a ##:## fashion to active drug versus placebo.

  • Allergy
  • Allergy Immunotherapy
  • Digestive System Disorder
  • Healthcare
  • Product Initiative

HALMRE-## - DRUG PROFILE POLLINEX QUATTRO GRASS - DRUG PROFILE Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description Pollinex Quattro Grass Allergy Therapeutics Plc NA GlaxoSmithKline Plc R& D Progress Resea

  • Allergy Drug
  • Healthcare
  • Ophthalmic Solution
  • Pharmaceutical
  • Product Initiative

Oneness Biotech Co Ltd (Oneness Biotech) is a biopharmaceutical company that conducts research and development of drugs.

  • Allergy Drug
  • Chronic Disease
  • Digestive System Disorder
  • Healthcare
  • Glenmark Pharmaceuticals Ltd.

These drugs are useful for treatment of inflammatory diseases, allergy, pain, , asthma, chronic obstructive pulmonary disease, rheumatoid arthritis, atopic dermatitis, psoriasis, eczema, pruritus, itchy skin, urticaria etc.

  • Antifungal
  • Healthcare
  • Pharmaceutical
  • World
  • Sensorion S.A.

The data were presented at the European Academy of Allergy and Clinical Immunology ##th Annual Congress 2016.

  • Antifungal
  • Healthcare
  • Pharmaceutical
  • World
  • Sensorion S.A.

The drug candidate is in Phase II stage for peanut allergy in adults and pediatrics, grass pollen allergy and dermatitis globally.

  • Antifungal
  • Digestive System Disorder
  • Healthcare
  • Monoclonal Antibody
  • United States

The company offers drugs in the areas of nephrology, oncology, immunology and allergy, central nervous system among others.

  • Blood Disease
  • Digestive System Disorder
  • Healthcare
  • Therapy
  • United States

The drug candidate is in Phase II stage for peanut allergy in adults and pediatrics, grass pollen allergy and dermatitis globally.

  • Antifungal
  • Digestive System Disorder
  • Healthcare
  • United States
  • Product Initiative

About ## percent of people who have food allergies are allergic to more than one food.

  • Digestive System Disorder
  • Healthcare
  • Respiratory Disease
  • United States
  • Product Initiative

IT WAS ALSO UNDER DEVELOPMENT FORAUTOIMMUNE DISEASES AND ALLERGIES.

  • Dermatology
  • Healthcare
  • United States
  • World
  • Product Initiative

Rituximab was well tolerated, and most adverse drug reactions were grade ##-## in severity.

  • Digestive System Disorder
  • Healthcare
  • Therapy
  • United States
  • Product Initiative

ABOUT ## PERCENT OF PEOPLE WHO HAVE FOOD ALLERGIES ARE ALLERGIC TO MORE THAN ONE FOOD.

  • Digestive System Disorder
  • Healthcare
  • Therapy
  • United States
  • Product Initiative

The drug candidate binds to and inhibits the mRNA of Orai ##, inhibiting the calcium transport.

  • Antifungal
  • Digestive System Disorder
  • Healthcare
  • Therapy
  • Aldeyra Therapeutics, Inc.

The drug candidate binds to and inhibits the mRNA of Orai ##, inhibiting the calcium transport.

  • Antifungal
  • Digestive System Disorder
  • Eye Disease
  • Healthcare
  • United States

PI##-KINASE DELTA IS EXPRESSED PRIMARILY IN BLOOD CELL LINEAGES, INCLUDING CELLS THAT CAUSE OR MEDIATE HEMATOLOGIC MALIGNANCIES, INFLAMMATION, AUTOIMMUNE DISEASES AND ALLERGIES.

  • Digestive System Disorder
  • Healthcare
  • Lymphoma
  • United States
  • Product Initiative

PI##-Kinase delta is expressed primarily in blood cell lineages, including cells that cause or mediate hematologic malignancies, inflammation, autoimmune diseases and allergies.

  • Digestive System Disorder
  • Healthcare
  • Therapy
  • United States
  • Product Initiative

THE DRUG CANDIDATE IS IN PHASE II STAGE FOR PEANUT ALLERGY IN ADULTS AND PEDIATRICS, GRASS POLLEN ALLERGY AND DERMATITIS GLOBALLY.

  • Allergy Drug
  • Digestive System Disorder
  • Healthcare
  • United States
  • Product Initiative

One patient had a fatal SAE, which was not drug related.

  • Antifungal
  • Digestive System Disorder
  • Healthcare
  • United States
  • Product Initiative

Efficacy was evaluated at Night ## (first drug administration) and after ## weeks of drug administration (Night ##).

  • Digestive System Disorder
  • Healthcare
  • Therapy
  • United States
  • Eisai Co., Ltd.

Two out of the six were considered possibly related to study drug: one in Group ## and one in Group ##.

  • Antifungal
  • Digestive System Disorder
  • Healthcare
  • Monoclonal Antibody
  • SCYNEXIS, Inc.

THE DRUG CANDIDATE IS IN PHASE II STAGE FOR PEANUT ALLERGY IN ADULTS AND PEDIATRICS, GRASS POLLEN ALLERGY AND DERMATITIS GLOBALLY.

  • Antifungal
  • Digestive System Disorder
  • Healthcare
  • Respiratory Disease
  • AstraZeneca PLC

Subjects orally took study drug once daily in the evening for one month.

  • Digestive System Disorder
  • Eye Disease
  • Healthcare
  • United States
  • Product Initiative

(allergy and autoimmune diagnostics) which was sold to Thermo Fisher Scientific (TMO) in September of 2011.

  • Healthcare
  • Research And Development
  • United States
  • Company
  • ProQR Therapeutics N.V.